Free Trial

Neogen Q4 2024 Earnings Report

Neogen logo
$12.04 +0.02 (+0.17%)
(As of 12/20/2024 05:16 PM ET)

Neogen EPS Results

Actual EPS
$0.10
Consensus EPS
$0.12
Beat/Miss
Missed by -$0.02
One Year Ago EPS
$0.14

Neogen Revenue Results

Actual Revenue
$236.80 million
Expected Revenue
$225.83 million
Beat/Miss
Beat by +$10.97 million
YoY Revenue Growth
-2.10%

Neogen Announcement Details

Quarter
Q4 2024
Time
Before Market Opens

Conference Call Resources

Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry. 

Neogen Earnings Headlines

Neogen initiated with a Buy at Guggenheim
Guggenheim sees Neogen ‘turning the corner,’ starts with a Buy
WARNING: “Buffett Indicator” flashing for first time in 50 years
Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.
Neogen® Announces Second-Quarter Earnings Release Date
See More Neogen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Neogen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neogen and other key companies, straight to your email.

About Neogen

Neogen (NASDAQ:NEOG), together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

View Neogen Profile

More Earnings Resources from MarketBeat

Upcoming Earnings